Compare KRMD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRMD | HLN |
|---|---|---|
| Founded | 1980 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.5M | 42.8B |
| IPO Year | 2019 | 2021 |
| Metric | KRMD | HLN |
|---|---|---|
| Price | $3.24 | $9.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | 168.2K | ★ 12.5M |
| Earning Date | 05-06-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | ★ 53.85 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,127,366.00 | N/A |
| Revenue This Year | $20.32 | $6.55 |
| Revenue Next Year | $17.37 | $4.42 |
| P/E Ratio | ★ N/A | $49.05 |
| Revenue Growth | ★ 22.23 | N/A |
| 52 Week Low | $3.09 | $8.65 |
| 52 Week High | $6.61 | $11.28 |
| Indicator | KRMD | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 38.96 |
| Support Level | $3.18 | $9.08 |
| Resistance Level | $3.43 | $10.20 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 42.93 | 17.73 |
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.